Today: 30 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Surges on New AI Push – Latest Price, Key News & 2025 Outlook

As of October 8, 2025, Amazon’s stock trades around $225 per sharestockanalysis.com. It has risen modestly in early October, bouncing from about $219 at the start of the month to the mid-$220s rangestockanalysis.com. This week’s ~1.5% uptick follows a period of volatility in late September. Year-to-date, AMZN is roughly flat to slightly up, lagging the broader S&P 500 and most other “Magnificent Seven” tech giants. Notably, Amazon hit an all-time high near $242 in early February 2025, but a summer tech sell-off and profit-taking pulled the stock down about 10% from that peakts2.tech. Chart-wise, Amazon’s current price sits in the middle of its 52-week rangets2.tech. The stock is trading right around its 50-day moving average and comfortably above the 200-day averagemarketbeat.com, suggesting an improving trend after the late-summer dip. Amazon’s beta ~1.3 indicates it’s slightly more volatile than the marketmarketbeat.com, which has been evident in its swings this year. Over a longer horizon, shares have nearly doubled in the past 3 yearsts2.tech, underscoring strong wealth creation despite recent consolidation. Overall, current levels imply the market is cautiously optimistic – pricing in Amazon’s robust fundamentals but also the lingering headwinds.
8 October 2025
···
Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI, Inc. is an American health technology company founded in 2015 by entrepreneur Eric Lefkofsky. Headquartered in Chicago, Tempus was born from Lefkofsky’s personal mission to improve cancer care after his wife’s battle with breast canceren.wikipedia.org. The company’s core focus is on applying AI and data analytics to personalized medicine. Tempus has built what it calls an “operating system” for healthcare: a platform that ingests vast amounts of clinical and molecular data and makes it accessible for treatment decisions and researchinsidermonkey.com. Its goal is to enable doctors and scientists to leverage big data and AI algorithms to tailor treatments to individual patients – improving outcomes in cancer and other diseases. In practice, Tempus provides both diagnostic tests and analytics services. For example, it offers genomic sequencing for tumor profiling, AI-driven diagnostic algorithms, and a suite of data tools that physicians can use to guide therapy selection. The company’s mission statement emphasizes “bringing the power of data and AI to healthcare”, aiming to glean insights from real-world patient data at scaleinsidermonkey.com. Over the past 10 years, Tempus has amassed one of the world’s largest libraries of de-identified clinical and genomic data, covering millions of patients. This data fuels its machine
8 October 2025
···
Rare Interstellar Comet 3I/ATLAS – a 10-Billion-Year-Old Time Capsule – Flies Past Mars

Rare Interstellar Comet 3I/ATLAS – a 10-Billion-Year-Old Time Capsule – Flies Past Mars

Humanity has waited a long time to study a comet from another star – and suddenly, within a decade, we’ve had three. 3I/ATLAS is the latest of these rare interstellar interlopers. It was first detected moving through the outer Solar System in June 2025 with an exceptionally eccentric orbit. Follow-up observations quickly confirmed what its speed and trajectory implied: this object was not bound to the Sun’s gravityts2.tech. By July 2025, the Minor Planet Center designated it the third interstellar object ever foundts2.tech. Like its predecessors – the cigar-shaped 1I/‘Oumuamua and cometary 2I/Borisov – 3I/ATLAS is an outsider: it originated around a distant star and is merely passing through our cosmic neighborhoodesa.int. What makes 3I/ATLAS especially exciting is that it’s the most “comet-like” interstellar visitor so far. ‘Oumuamua was puzzlingly inert and Borisov, while clearly a comet, never came very close to the Suntheguardian.com. In contrast, 3I/ATLAS is big, bright, and active, venting gas and dust as it approaches the Sunts2.techts2.tech. “You wait ages for an interstellar comet to arrive and then three come along at once,” joked science writer Ian Sampletheguardian.com – but 3I/ATLAS might be the one that truly opens a window onto other worlds. As Dr. Michael
8 October 2025
·
Google’s Pixel 10 Pro Fold Shakes Up the Smartphone Wars with AI Tricks, Durability & Bold Design

Google’s Pixel 10 Pro Fold Shakes Up the Smartphone Wars with AI Tricks, Durability & Bold Design

Google’s new Pixel 10 Pro Fold is the star of its 2025 lineup – a device that blends cutting-edge hardware with Google’s latest AI software. This foldable phone is branded as the “Pro Fold” variant of the Pixel 10 family, emphasizing that it shares the same core specs and AI features as the Pixel 10 Pro slab phonests2.tech. When closed, it looks like a typical premium smartphone with a 6.4″ OLED display; opened up, it reveals a spacious 8″ tablet-like screen – slightly larger than its predecessor and rival Galaxy foldsts2.tech. The design retains Pixel’s signature aesthetics, but with notable engineering upgrades: Google redesigned the hinge mechanism to a gearless system, which not only makes folding motion smoother but is rated for over 100,000 folds without failurets2.tech. In practical terms, Google says the hinge should last 10+ years of average use – addressing durability concerns that often plague foldables. Perhaps the Pixel 10 Pro Fold’s biggest selling point is its durability. It is the first foldable smartphone ever to achieve an IP68 rating, meaning it’s fully sealed against dust and waterts2.tech. This is a significant leap – even Samsung’s latest Galaxy Z Fold 7 is only IPX8ts2.tech. With the Pixel
8 October 2025
···
Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic’s stock was relatively quiet for most of 2025 until early October, when it suddenly erupted. By Oct 8, 2025, XBIO had skyrocketed to levels not seen in years. On that day alone, the stock soared 123% to $9.58finanzen.ch, after touching intraday highs well above $10. This move extended a remarkable run from under $3.50 at the start of the week to nearly $12-13 intraday on Oct 8ainvest.com. In fact, at one point XBIO was up about +195% in a single session according to real-time trackerstimothysykes.com. Such gains are extraordinary – even by penny stock standards – and placed XBIO among the top percentage gainers across the entire Nasdaq. To put the rally in context, Xenetic’s stock had been languishing in the low-single-digits. On Oct 3, 2025, it hit a 52-week low around ~$2.80ainvest.com. From that low to Oct 8’s peak, XBIO shot up roughly 3.5-fold in a matter of days. The chart went vertical, catching many investors by surprise. Notably, trading volume exploded in step with the price spike – from only ~4,000 shares on Oct 2 to 27+ million shares on Oct 8thestockcatalyst.com. That volume represents many times the total float.
8 October 2025
··
Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Above Food Ingredients Inc. is a Canadian plant-based food tech company that went public via SPAC merger in 2024 Stocktwits. In 2025, its stock ABVE has been on a wild ride – climbing from penny-stock levels to over $4, an almost 8-fold increase in under a year Marketbeat. This meteoric rise comes as Above Food pivots beyond organic grains into gold-backed cryptocurrencies and next-gen financial tech, capturing investor imagination. Below, we dive into Above Food’s mission, business model, financials, stock performance, forecasts, expert commentary, strategic moves, ESG profile, and the latest news driving this micro-cap’s buzz. Founded in Regina, Saskatchewan, in 2023, Above Food began with a straightforward vision: “to create a healthier world — one seed, one field, and one bite at a time.” Abovefood The company started as a regenerative agriculture and food technology venture, focusing on sustainably grown plant proteins and specialty ingredients. Through a vertically integrated supply chain – from proprietary seeds and farming to in-house processing – Above Food delivers nutritious plant-based ingredients and consumer products globally Abovefood.
8 October 2025
··
Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining Inc. is a pure-play Bitcoin miner operating industrial-scale data centers with a focus on ultra-low-cost powerts2.tech. The company strategically locates its facilities in regions with cheap, renewable-rich electricity, often building behind-the-meter or adjacent to wind and solar farmsts2.techts2.tech. Its flagship “Black Pearl” site near Odessa, TX is a 150 MW facility designed for both Bitcoin mining and high-performance computing workloadsts2.tech. As of mid-2025, Cipher’s deployed hashrate reached about 16.8 EH/s, using next-gen ASIC machines for high energy efficiencyts2.tech. The company had aggressively expanded capacity – a 2.6 GW development pipeline of power projects positions Cipher for further growthts2.tech. Management guided toward ~23.5 EH/s of self-mining capacity by Q3 2025ts2.tech, indicating continued installation of miners and facility build-outs. This would place Cipher among the largest global Bitcoin miners by hashrate. Notably, its operations produced ~150 BTC in Q2 2025 and the firm plans further upgrades beyond 2025 to stay at the cutting edgets2.techts2.tech.
8 October 2025
···
Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune’s stock has been on a rollercoaster in 2025, epitomizing the volatility of small-cap biotech. After a prolonged decline to mere pennies, ADAP staged a spectacular rally in late September. On Sept 19, heavy trading momentum saw the stock open at just $0.08 and close at $0.16 – a 98% single-day jump. It didn’t stop there: in after-hours trading, ADAP leapt another 30% to $0.2020 Nasdaq despite no new company news that day Nasdaq. This frenzy was highlighted in market reports as one of the most active stocks, with 705 million shares changing hands Nasdaq. Fast-forward to early October, and the stock was still extremely volatile. After pulling back to the mid-teens, ADAP once again skyrocketed ~42% on Oct 8, 2025, hitting roughly $0.20intraday Marketbeat. This surge coincided with a flurry of trading interest – by mid-day Oct 8, ADAP was up ~38.5% on volume exceeding 400M shares, making it one of the top gainers on NASDAQ that session Chartmill. The absence of any fresh catalyst suggests the move was driven by technical trading, short covering, or investor speculation rather than fundamentals.
8 October 2025
·
Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Below, we dive deeper into each of these areas – from Snowflake’s business model and financials to the latest news, analyst insights, competitive dynamics, and what to expect going forward. Snowflake Inc. is a cloud data platform provider, offering data warehousing as a service alongside a suite of data analytics and sharing capabilities. Unlike traditional databases tied to a single cloud or on-premises, Snowflake’s platform is cloud-agnostic – it runs across Amazon AWS, Microsoft Azure, and Google Cloud, allowing customers to unify their data in one system regardless of cloud providermarkets.chroniclejournal.com. This flexibility has been a major selling point for enterprises adopting multi-cloud strategies.
8 October 2025
···
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

Sources: Official company reports and press releases; Yahoo Finance and Zacks Investment Research; Reuters and CNBC interviews; TS2 Tech stock analysis and cybersecurity newsts2.technasdaq.commarkets.financialcontent.commarketbeat.comts2.techsiliconangle.comts2.tech. These provide the latest financial data, expert commentary, and industry context as of October 8, 2025.
8 October 2025
···
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025, the stock closed at $27.34, down roughly 0.7% from $27.54 on the prior sessionstockinvest.us. Technical analysts at Stockinvest.us noted the shares were near the upper part of a wide falling trend and predicted a possible trading range of $26.40–$28.73 on Oct 8, with longer‑term support around $26 and resistance near $31stockinvest.us. While short‑term signals were positive, they cautioned that the overall downward trend remainsstockinvest.us. Because multiple financial data sites blocked direct access, we rely on StatMuse and StockAnalysis for market capitalization. StatMuse lists Moderna’s market value at about $11.2 billion based on a $28.51 share price with roughly 391.93 million shares outstandingstatmuse.com. StockAnalysis shows that at Oct 8 2025 1:24 PM EDT the stock traded near $28.44 and the market cap was about $11.07 billionstockanalysis.com. These valuations are a fraction of Moderna’s pandemic‑era peak and highlight the steep decline in investor expectations.
8 October 2025
··
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Intellia’s October rally was triggered by longer‑term Phase 1 results for nexiguran ziclumeran, an in‑vivo CRISPR therapy for transthyretin amyloidosis. A GlobeNewswire release reported that a single dose produced a rapid, deep and durable reduction of serum TTR levels—mean reduction 92 % at 24 months and 90 % at 36 monthsglobenewswire.com. Patients also showed clinical improvements or stabilization of neuropathy and cardiac markersglobenewswire.com, and safety findings were mostly mild infusion‑related eventsglobenewswire.com. CEO John Leonard said the data “demonstrate rapid, deep and durable TTR reductions with meaningful clinical improvements” and reiterated plans to complete enrolment in the Phase 3 MAGNITUDE‑2 trial in the first half of 2026globenewswire.comglobenewswire.com. The strong data sparked buying. MarketBeat noted that on 8 October 2025 the stock jumped 6.6 % to $21.80, while trading volume was 88 % below averagemarketbeat.com. Analysts responded with upgrades; HC Wainwright raised its price target from $25 to $30marketbeat.com, and the consensus target reached $27.95marketbeat.com. Simply Wall St highlighted that ARK Investment’s purchase of 99,000 shares after the data underscored investor optimismsimplywall.st.
8 October 2025
··
CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

According to AAII, CRSP’s share price on 8 Oct 2025 closed at $77.727, up 10.06 % from the previous close. The stock traded between $70.77 and $78.38 that day and has risen ~20 % during October. Over the prior year the share price ranged from $30.04 to $73.95, and year‑to‑date performance stood at +97.5 %. Trading volume on INDmoney’s quote was 3.1 million sharesindmoney.com. Fintel’s data as of 7 Oct 2025 list a market cap of roughly $6.2 billion, a beta of 1.32 and a short interest of 26.3 %, suggesting significant volatility and short‑seller interestfintel.io. The average one‑year price target of $81.3 implies modest upside relative to the Oct 8 closefintel.io. Directorstalk’s technical analysis notes that the 50‑day moving average is above the 200‑day and the relative‑strength index near 60, reflecting bullish momentumdirectorstalkinterviews.com. AAII’s momentum grade also classifies the stock as strong momentum.
8 October 2025
·
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics, Inc. is a clinical-stage biotechnology company at the forefront of CRISPRgene editing medicines. Headquartered in Cambridge, MA, Intellia was one of the first companies to harness CRISPR-Cas9 technology to develop potential in vivo therapies – treatments delivered directly into the body to edit genes inside patients’ cells. In fact, Intellia reported the first-ever clinical evidence that CRISPR could provide a therapeutic benefit in humans via in-body gene editing, showing in 2021 that a one-time IV infusion could drastically lower a disease-causing protein in patients ts2.tech. This pioneering achievement, accomplished with their transthyretin amyloidosis program, has put Intellia on the map as a trailblazer in genomic medicine. Today, Intellia’s mission is to develop curative treatments for severe diseases with few options, by editing or knocking out malfunctioning genes at the source. Its pipeline spans both in vivo therapies and ex vivo approaches. Intellia’s platform and know-how – based on Nobel Prize-winning science – have attracted top-tier collaborators. For example, Regeneron Pharmaceuticalspartnered with Intellia back in 2016, providing expertise to co-develop CRISPR treatments. This alliance has already borne fruit: Regeneron and Intellia’s lead candidate NTLA-2001 for ATTR amyloidosis emerged from their collaboration, and the partners even expanded the deal in
8 October 2025
···
TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

Taiwan Semiconductor Manufacturing Co. is the world’s largest contract chipmaker, producing advanced semiconductors for clients like Apple, NVIDIA, AMD, and many otherstaiwannews.com.twts2.tech. Rather than selling its own branded chips, TSMC builds chips to order, focusing on cutting-edge manufacturing processes. This model has made TSMC a pillar of global tech supply chains and given it an estimated 60%+ market share of the overall foundry marketts2.tech. Financially, TSMC has been on a strong growth trajectory. In Q2 2025, TSMC’s revenue reached US$30.1 billion, a 44%year-on-year surge, with net profit of T$398.3 billion, driven by booming orders for high-performance chipsts2.tech. For the first half of 2025, sales totaled about US$60.5 billionts2.tech. TSMC’s management has guided Q3 2025 revenue in the US$31.8–33 billion range and signaled roughly 30% full-year revenue growthts2.tech – an impressive clip for a company of its size. Gross profit margins remain very high, reflecting TSMC’s pricing power and efficient scale. The company plans to invest US$38–42 billion in capital expenditures this year to expand capacity and maintain its technology edgets2.tech.
8 October 2025
··
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Inc. – the world’s largest company by market capitalization – has had a mixed 2025 so far. With a market cap around $3.8 trillionts2.tech, Apple’s size means even modest growth is hard-fought. Year-to-date, AAPL stock is roughly flat, underperforming the broader tech sectorts2.tech. This muted performance comes despite Apple achieving record financial results in 2025ts2.tech. Early in the year the stock sold off amid market rotation and AI hype elsewhere, at one point down ~17%. But a strong rebound in late summer – fueled by booming iPhone sales – brought Apple’s stock back near all-time highs heading into Octoberts2.techts2.tech. Investors have been cautiously optimistic. Apple’s fiscal Q3 2025 earnings handily beat forecasts, with EPS $1.57 vs $1.43 expected and broad-based growth across iPhone, Mac, and Services segmentsts2.tech. The company even raised its outlook, projecting an acceleration to mid/high single-digit revenue growth for Q4 2025ts2.tech. Those results, plus the successful launch of the iPhone 17, helped restore confidence and pushed AAPL stock into an uptrend. By late September, shares traded around $255, making Apple slightly positive for 2025 and putting a $4 trillion market cap within reachts2.techts2.tech.
8 October 2025
··
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco Systems is best known as the world’s largest vendor of networking hardware and software, powering much of the internet’s infrastructure. The company’s business model centers on selling network equipment, along with security solutions, collaboration tools, and observability software. In addition, Cisco provides a range of services – from technical support and maintenance contracts to cloud-managed software subscriptions. Cisco generates revenue both through direct sales and via a global channel of resellers and distributors, ensuring its products reach enterprises of all sizes and governments worldwidenasdaq.com. This mix of one-time product sales and recurring service or subscription fees has made Cisco’s cash flows quite robust. Geographically, the Americas contribute the majority of revenue, with EMEA and Asia-Pacific regions also significant.
8 October 2025
··
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group’s share price has been volatile in 2025. On 8 Oct 2025 the stock closed around $372—IndMoney quoted $372.93 while Investing.com listed $372.64indmoney.cominvesting.com. Reuters reported that the last trade was $371.46, up 2.15 % from the previous dayreuters.com. The wide 52‑week range highlights the enormous drawdown from April’s peak and underscores the severity of the 2025 sell‑off. The stock’s average daily trading volume is about 5.9 million shares, and its beta of 0.47 indicates less volatility than the S&P 500reuters.commarketbeat.com. Year‑to‑date performance remains negative, but shares have rebounded more than 10 % over the past monthindmoney.com. The sharp recovery reflects investor optimism that 2025’s profit slowdown could be temporary.
8 October 2025
·
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit’s Rollercoaster: How Booming Ads, AI Deals and Political Scrutiny Could Shock RDDT Investors

Reddit’s shares have been volatile since the company’s March 2024 IPO. On 8 Oct 2025 the stock traded near $200, down roughly 30 % from its 52‑week high but still well above the IPO price. The intraday swing between $195 and $206 suggests heightened sensitivity to newsinvestor.redditinc.com. The stock spiked in late July after Reddit posted its first profitable quarter but pulled back in early October amid concerns over artificial‑intelligence data‑licensing value and declining ChatGPT citationsmarkets.financialcontent.com. Overall, analysts view the dip as a buying opportunity, noting that the company’s advertising growth and data‑licensing agreements provide a solid foundationmarkets.financialcontent.com. Financial analysts remain broadly optimistic about Reddit’s prospects. RBC Capital raised its price target to $245 after assessing ad loads across social platforms and finding that Reddit’s ad load increased low‑double digits—more than peers such as Meta, Google, Pinterest and Snapinvesting.com. RBC said the probability of continued revenue outperformance outweighs any short‑term risks from slowing daily‑active‑user growthinvesting.com. The firm also noted an evolving question: how generative AI models will refer traffic back to websites, meaning the value of content licensing could changeinvesting.com. Another RBC note flagged concerns that SimilarWeb data showed declining daily active users and that Reddit’s ChatGPT citation share dropped
8 October 2025
··
Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

Sources: Palo Alto Networks and CyberArk deal coverage – Reutersreuters.comreuters.com; Q4 2025 earnings and guidance – Reutersreuters.com, Futurumfuturumgroup.comfuturumgroup.com; Analyst ratings and price targets – StockAnalysisstockanalysis.comstockanalysis.com; Competitive landscape – Bullish Bearsbullishbears.combullishbears.com; Unit 42 threat intel news – ts2.techts2.tech; Expert quotes – Reutersreuters.com, Breakingviewsreuters.com; Stock performance data – Yahoo/Benzingahotcandlestick.com.
8 October 2025
···
1 … 285 286 287 288 289 … 397

Stock Market Today

  • Sandisk Seen Rising After Strong Quarter, Analysts Say
    June 30, 2026, 12:40 PM EDT. Analysts expect Sandisk shares to climb after the company posted record results. Memory stocks have been in focus as investors look for AI-related plays. Analysts pointed to Sandisk's showing as a sign of possible further upside, with AI driving more attention to memory tech.
Go toTop